MedicarePartD.guide

A non-government resource built from CMS public data

Xolair on Wellcare Value Script (S4802-133)

omalizumab

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 1 per 28 days.

$348.04
Patient pays / month, after deductible
$809.29
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

XOLAIR PFS 75 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $1,392.14 for a month. Other covered strengths are listed below.

Prior authRequired on all 7 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 7 covered strengths and forms
FormTierPatient pays / monthLimits
XOLAIR 150 mg/1.2mL Injection, Solution5$3,482.59PA · 8 per 28 days
XOLAIR PFS 75 mg/.5mL Injection, Solution5$348.04PA · 1 per 28 days
XOLAIR PFS 75 mg/.5mL Injection, Solution5$351.11PA · 1 per 28 days
XOLAIR PFS 150 mg/mL Injection, Solution5$3,315.75PA · 8 per 28 days
XOLAIR PFS 150 mg/mL Injection, Solution5$3,203.91PA · 8 per 28 days
XOLAIR 300 mg/2mL Injection, Solution5$3,585.10PA · 8 per 28 days
XOLAIR 300 mg/2mL Injection, Solution5$3,289.18PA · 8 per 28 days

Other Asthma and COPD biologics on this plan

Verify with the plan before prescribing or filling. Member services: (888)550-5252. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s4802-133